Diabetic cardiomyopathy: where are we 40 years later?
Diabetic cardiomyopathy is a cardiac disease that arises as a result of the diabetic state, independent of vascular or valvular pathology. It manifests initially as asymptomatic diastolic dysfunction, which progresses to symptomatic heart failure. The compliance of the heart wall is decreased and contractile function is impaired. The pathophysiology is incompletely understood, but appears to be initiated both by hyperglycemia and changes in cardiac metabolism. These changes induce oxidative stress and activate a number of secondary messenger pathways, leading to cardiac hypertrophy, fibrosis and cell death. Alterations in contractile proteins and intracellular ions impair excitation-contraction coupling, while decreased autonomic responsiveness and autonomic neuropathy impair its regulation. Extensive structural abnormalities also occur, which have deleterious mechanical and functional consequences.
Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Science, University of British Columbia, Vancouver, Canada. vijaysha@interchange.ubc.ca
V
V
Sharma
John H
JH
McNeill
D009202:Cardiomyopathies / Q000209:etiology*; D048909:Diabetes Complications / Q000209:etiology* / Q000378:metabolism*; D006801:Humans